Question 1

Does Moore Capital Management own TXG stock?

Accepted Answer

No. Moore Capital Management exited its TXG (10x Genomics) position in Q4 2025. Its Q3 2025 13F listed 54,216 shares worth $633,785.

Question 2

How many shares of TXG does Moore Capital Management own?

Accepted Answer

None since Q4 2025, when Moore Capital Management exited the position. Its Q3 2025 13F listed 54,216 shares worth $633,785.

Question 3

What is Moore Capital Management's TXG position worth?

Accepted Answer

Moore Capital Management's TXG position was worth $633,785 in its Q3 2025 13F, before the exit in Q4 2025.

Question 4

Is Moore Capital Management buying or selling TXG?

Accepted Answer

In Q4 2025, Moore Capital Management exited its entire TXG position.

Question 5

When did Moore Capital Management first buy TXG?

Accepted Answer

Moore Capital Management first reported TXG in its Q1 2023 13F and listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$16.29	0
2025-Q3	Decreased	54,216	-31.2%	$633,785	0.0%	$11.34	0
2025-Q2	Decreased	78,768	-62.5%	$912,133	0.0%	$11.73	0
2025-Q1	New	210,230	—	$1.8M	0.0%	$9.16	36